Topic:
Personalized Medicine
Latest Headlines
Latest Headlines
Drug boosts effectiveness of radiation therapy for brain tumors
An enzyme inhibitor that helps repair DNA damage may provide a new way to boost the effectiveness of radiation therapy for a lethal type of brain cancer.
Bristol-Myers Squibb pursues cancer biomarker development deal
Bristol-Myers Squibb will collaborate with Adaptive Biotechnologies to develop immunological biomarkers for cancer, representing another step forward in the development of personalized medicine.
Intel, Oregon Health & Science University partner on genetic profiling project
In an ambitious effort to find more personalized treatments for cancer and other complex diseases, Oregon Health & Science University in Portland and Intel are teaming up to develop new computing technologies to map an individual's genetic profile more quickly, precisely and cost-effectively.
Columbia researchers identify hundreds of potential metabolic cancer targets
Scientists have identified multiple metabolic expression changes associated with cancer as well as hundreds of new potential drug targets that could cut off a tumor's fuel supply or interfere with its ability to produce essential building blocks.
Antibody genes linked to ethnicity
Scientists think they've found a link between antibody makeup and ethnicity--evidence that that some ethnic groups may be more susceptible to certain diseases or respond to diseases differently than people of other backgrounds.
Abbott aids biotech Epizyme in matching epigenetic drug with cancer patients
The agreement follows the start of a Phase I study of the compound, EPZ-5676, for which biotech giant Celgene has partnered with the startup for development outside the U.S.
Agios compounds could be alternative treatment to chemo for leukemia, brain cancer
Agios Pharmaceuticals may be one step closer to finding a breakthrough approach to treat cancer in a more personalized fashion.
New class of Merck drugs targets therapy-resistant cancer
Researchers at Merck are developing a class of new drugs that could help improve treatment options for patients with certain cancers driven by genetic mutations.
One-two vaccine punch against ovarian cancer takes center stage at AACR
In a small study mounted at the University of Pennsylvania, a novel combination approach using a personalized therapeutic vaccine made from dendritic cells primed with a patient's tumor cells was successfully used to fight advanced ovarian cancer.
Celgene-backed Agios and Foundation partner in breakthrough cancer strategy
Agios has teamed up with Foundation Medicine to find patients with the genetic profiles most suited to treatment on Agios therapies concerning two cancer metabolism targets.
